BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+33.77%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$15.6B
AUM Growth
+$15.6B
Cap. Flow
+$12.7M
Cap. Flow %
0.08%
Top 10 Hldgs %
85.51%
Holding
100
New
7
Increased
16
Reduced
6
Closed
4
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PRNB
26
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$60.8M 0.39% 1,787,807
INSM icon
27
Insmed
INSM
$28.8B
$60.4M 0.39% 2,077,601 +225,619 +12% +$6.56M
KOD icon
28
Kodiak Sciences
KOD
$478M
$59.7M 0.38% 9,145,115
KNSA icon
29
Kiniksa Pharmaceuticals
KNSA
$2.48B
$54.2M 0.35% 3,000,000
MYOK
30
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$52.8M 0.34% 1,016,306 +701,063 +222% +$36.4M
DBVT
31
DBV Technologies
DBVT
$264M
$42.5M 0.27% 5,509,560
QURE icon
32
uniQure
QURE
$896M
$36.1M 0.23% 605,000
NGNE icon
33
Neurogene
NGNE
$264M
$29.5M 0.19% 10,934,154
ZYME icon
34
Zymeworks
ZYME
$1.12B
$27.6M 0.18% 1,708,472
KRYS icon
35
Krystal Biotech
KRYS
$4.27B
$25.8M 0.17% 784,674
RARX
36
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$18.4M 0.12% 823,113
MRUS icon
37
Merus
MRUS
$4.98B
$17.1M 0.11% 1,160,014
AXSM icon
38
Axsome Therapeutics
AXSM
$6.05B
$17.1M 0.11% +1,200,000 New +$17.1M
AIMT
39
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$15.1M 0.1% 673,908
CPRX icon
40
Catalyst Pharmaceutical
CPRX
$2.52B
$14.8M 0.09% 2,900,000
SYRE icon
41
Spyre Therapeutics
SYRE
$996M
$13.8M 0.09% 1,713,604
XNCR icon
42
Xencor
XNCR
$580M
$13.3M 0.09% 428,120 -12,066 -3% -$375K
ACGN
43
DELISTED
Aceragen, Inc. Common Stock
ACGN
$12.3M 0.08% 4,839,895 +3,658 +0.1% +$9.33K
DERM
44
DELISTED
Dermira, Inc.
DERM
$12.3M 0.08% +906,943 New +$12.3M
MRKR icon
45
Marker Therapeutics
MRKR
$12M
$9.9M 0.06% 1,500,000
SGMO icon
46
Sangamo Therapeutics
SGMO
$157M
$9.54M 0.06% 999,823
ABEO icon
47
Abeona Therapeutics
ABEO
$350M
$9.48M 0.06% 1,288,235 -814,929 -39% -$6M
BLCM
48
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$9.02M 0.06% 2,677,818
ANAB icon
49
AnaptysBio
ANAB
$569M
$8.26M 0.05% 113,086
ALBO
50
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$8.05M 0.05% 250,000